Navigation Links
Creabilis Awarded Prestigious European Commission FP7 Grant to Further Develop its LSE 'Topical-by-Design' Technology
Date:4/23/2013

ed TrkA kinase inhibitor developed using the Company's Low Systemic Exposure (LSE) technology. CT327 is currently in late stage clinical development for diseases of dermatology. CT340 is a potent kinase inhibitor under development for the treatment of pain.

Creabilis is backed by some of the most highly respected life sciences investors including Sofinnova Partners, Neomed and Abbott Biotech Ventures, Inc (now AbbVie Biotech Ventures).

Creabilis FP7 Project - Further Information

The full title of the FP7 project is 'LSE-LSE technology approach to generate innovative kinase inhibitor drugs'. The project number is 305272.

 

For further information please contact:

Creabilis
Eliot Forster
eforster@creabilis-sa.com
Creabilis SA
15 rue Edward Steichen
L-2540 Luxembourg

Citigate Dewe Rogerson
Chris Gardner or Nina Enegren
Tel: +44-(0)-20-7282-1050
E-mail: nina.enegren@citigatedr.co.uk


'/>"/>
SOURCE Creabilis SA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Combat Medical Systems Awarded $86 Million DOD Contract
2. Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
3. CCS Medical Awarded Medicare Contract
4. GE alliance awarded contract to design new plant-based manufacturing facility in Brazil
5. Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA
6. Pharmaceutical Executive Magazines 2013 Drug "Brand of the Year" Awarded to Leading Merck Diabetes Drug Januvia
7. Romark Laboratories Awarded Contract For Late-Stage Development Of New Influenza Drug
8. MEDICOMP Medical Awarded GSA Schedule, Will Supply VA Hospitals
9. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
10. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
11. Kalyspo Awarded Best of Ann Arbor SPARK Boot Camp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... ® Technologies, Inc., the leader in non-invasive, accelerated orthodontic ... to continued demand from orthodontists and patients for safe, ... locations in the U.S. and Canada ... the only FDA-cleared Class II medical device that has ... much as 50 percent.  A recent ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 /PRNewswire/ ... that Jennifer Simpson , Ph.D., M.S.N., C.R.N.P. ... by the Company,s Board of Directors, effective immediately.  ... Chief Executive Officer of Delcath since September 2014 ... from September 2013 to September 2014.  She joined ...
(Date:5/26/2015)... 26, 2015  LabStyle Innovations Corp. (DRIO), ... announced today that in partnership with ... Healthcare, it has launched  the comprehensive Dario™ ... advanced Telecare unit (MOMA). The Dario™ is ... enables remote treatment for diabetes aiming to ...
Breaking Medicine Technology:OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3Delcath Names Dr. Jennifer Simpson President And CEO 2Delcath Names Dr. Jennifer Simpson President And CEO 3Delcath Names Dr. Jennifer Simpson President And CEO 4LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4
... study broadens Phase 3 clinical program to further evaluate the ... April 15 Pfizer (NYSE: PFE ) and ... announced the initiation of a 12-month, Phase 3 clinical trial ... CONCERT, is designed to evaluate the safety and efficacy of ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ) today announced that ... study to evaluate the safety and tolerability of PCI-32765,an ... Btk,as a potential treatment for patients with relapsed or ... first Btk selective inhibitor to,be tested in humans, and ...
Cached Medicine Technology:Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 2Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 3Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5
(Date:5/26/2015)... Neeta Pai was diagnosed with HHT ... spells, four of which landed her in the emergency ... , Though she still struggles with anemia, iron deficiency ... time to increasing HHT awareness and garnering support for ... we could have prevented all the heartbreak and trauma ...
(Date:5/26/2015)... Sexual harassment and sexual assault are major ... known for creating opportunities in women's athletics, it is now ... and prevention. In a recent episode of SCI TV ... explains what Title IX means for university administrators dealing with ... this issue to protect students. , In the last 15 ...
(Date:5/26/2015)... senior industry executives are expected at the Suburban Collection ... connected car. A very special attraction for the clear-headed ... driver’s brain waves. Visitors to its booth will be ... just by gripping the steering wheel! , Peter Freer, ... cognitive load, altering music based on the driver’s mood, ...
(Date:5/26/2015)... 26, 2015 Relias Learning , ... the health and human services market, announces expansion of ... After strong attendance and participation in 2014, they will ... their annual user conference an exciting new facelift. ... come together and discuss best practices, share their expertise, ...
(Date:5/26/2015)... Mr. Larry Westenberg is a Licensed ... Programming, or NLP. Mr. Westenberg is recently also ... or RRT®. While many people have learned small ... to specific areas, Mr. Westenberg has been studying the ... years. He works with people suffering the effects ...
Breaking Medicine News(10 mins):Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3
... Re-elect Directors, Ratify E&Y and Approve Charter Amendment; ... Board Re-appoints Leadership, ... the "Company") said today that its Board of Directors declared,a regular ... 2008 to stockholders of record on June 4, 2008. The dividend ...
... Calif., May 19 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... S.,Williams has rejoined the company in a ... a wholly owned subsidiary of Alexza. Mr.,Williams ... Alexza,subsidiary in Singapore and establishing potential joint ...
... VALLEY FORGE, Pa., May 19 The St. Jude ... first drywall ever manufactured at the,new CertainTeed Gypsum Plant ... for St. Jude Children,s Research Hospital, CertainTeed is,donating gypsum ... the,house., (Logo: http://www.newscom.com/cgi-bin/prnh/20070102/CLTU053LOGO ), The ...
... Provides Development Expertise for Partners ... Developing on the Google Health Platform, PORTLAND, Ore., May ... and development company, announced,collaboration today with Google as a development ... to the public at an,event at Google,s headquarters today; the ...
... Program seeks to advance knowledge of mysterious conditions , , ... program designed to help patients with mysterious health conditions ... U.S. National Institutes of Health. , The Undiagnosed Diseases ... to the NIH Clinical Center by doctors across the ...
... of Nebraska Medical Center-led pilot study that showed antidepressants ... and neck cancer patients is the focus of an ... one of the publications produced by the Journal of ... led by UNMCs William Lydiatt, M.D., and Bill Burke, ...
Cached Medicine News:Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 4Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 5Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 2Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 3Health News:Gypsum Wallboard from CertainTeed's Moundsville, W. Va., Plant and Roofing Shingles among Building Materials Donated to St. Jude Dream Home(R) 2Health News:Mount Tabor Collaborates with Google Health 2Health News:U.S. Turns Spotlight on Medicine's Most Puzzling Cases 2Health News:JAMA publication features study on depression and head and neck cancer 2
This standard tying forcep is curved with 5mm titanium coated platforms. Length 85 mm....
Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
Kelman - McPherson tying forceps with serrated handle, platform 4 mm and overall length of 85 mm....
Troutman tying forceps are curved, delicate, bullet shape, with tying platforms. Flat pattern. Ultra fine platforms ideal for 10-0 or 11-0 suture material. Platforms fully meet to hold suture firmly....
Medicine Products: